8 Electronic Data Capture (EDC) Providers for Clinical Trials in 2026

An EDC provider builds the software clinical trial sites use to record and manage patient data electronically, in place of paper case report forms, forming the central data repository most other clinical trial systems connect back to. This kind of EDC provider ranges from long-established platforms that have processed millions of patients over decades to newer AI-enabled systems that automate study database builds directly from a trial protocol, and most now bundle EDC with adjacent modules like eCOA, eConsent, and RTSM rather than selling data capture as a standalone tool.

The EDC providers below are listed in no particular order. Between them, these companies and providers cover long-established enterprise EDC platforms, AI-driven study build automation, biometrics-focused CROs offering EDC as part of a data management service, and integrated eClinical suites combining EDC with RTSM, CTMS, and patient engagement tools.

Anju Software

Anju Software's flagship EDC product, TrialMaster, lets clinical teams build studies faster than competing systems through a Parameterized Edit Check feature that allows edit checks to be reused across multiple trials rather than rebuilt each time. Founded in 2016 and based in Tempe, Arizona, the company was acquired by Valsoft in August 2024 and has continued expanding its product line as a Valsoft portfolio company. In December 2025, Anju launched Luminee, an AI engine that reads and interprets a study protocol to automatically generate a validated, inspection-ready EDC database, including visit structures, forms, and edit checks — a product that won the SCOPE EU 2025 Innovation Award. TrialMaster also includes a mobile-enabled eConsent capability built directly into the EDC platform, letting patients complete consent, video testimonials, and comprehension assessments from within the same case report form.

Clincase

Clincase operates an end-to-end EDC and clinical data management platform that has been deployed in more than 400 studies covering over 100,000 subjects, used by CROs, research centers, and university hospitals across Europe, the US, and Asia. The company, based in Berlin, describes itself as having nearly 20 years of experience with EDC software, and runs its system as a zero-footprint, browser-based solution with clinical trial data hosted in a fully redundant German data center that mirrors to a secondary site daily. Clincase integrates ePRO questionnaires, randomization, drug supply management, and risk-based monitoring support directly within its EDC modules, letting sponsors avoid managing separate systems for each function. One long-term customer cited using Clincase as its preferred EDC system for more than 15 years, across both decade-long observational studies and complex Phase I/II oncology trials.

Clinion

Clinion runs an AI-enabled eClinical platform combining EDC, RTSM, CTMS, ePRO, eConsent, eSource, and document automation into a single system, with AI features built into the EDC core rather than layered on top, covering study setup, CDASH mapping, remote source data verification, and medical coding. Founded in 2010 and headquartered in Austin, Texas with development operations in Hyderabad, India, the company was named the Top Clinical Trial Management Solution Provider of 2023 by an industry publication. Clinion's platform includes a DICOM image repository that lets clinical teams upload and manage trial imaging data within the EDC system, with AI automatically redacting protected health information from images in under 30 seconds. The company's CSR automation tool uses AI to extract information from a trial's protocol, statistical analysis plan, and tables, listings, and figures, automatically populating up to 70 percent of a clinical study report while maintaining ICH E3 compliance.

EvidentIQ

EvidentIQ Group operates a portfolio of eClinical platforms built for different stages of the clinical research lifecycle, including Dacima, a highly configurable EDC platform for complex study designs, and Clindex, a system combining EDC, CTMS, eTMF, and eCOA/ePRO into one integrated environment. Founded in 2020 and based in Berlin, the company also operates Carenity, a patient engagement and real-world evidence platform providing direct access to online patient communities spanning more than 500,000 people across more than 1,200 chronic and rare disease areas. Group CEO Andreas Weber has described EvidentIQ's approach as starting earlier in the trial design process than typical eClinical vendors, consulting directly with sponsors on which trial elements can be delivered virtually versus in person. The company positions itself as a digital CRO combining eClinical technology with clinical research expertise to support trial execution from first-in-human studies through post-market real-world evidence programs.

Medidata

Medidata Rave EDC is described by the company as the gold standard of clinical research software, serving as the cornerstone of the broader Medidata Platform used across more than 38,000 clinical trials and 12 million patients since the company's 1999 founding. Now a Dassault Systèmes brand headquartered in New York City, Medidata launched Rave Companion in 2022, a patent-pending tool that automates the transfer of EHR data directly into Rave EDC to reduce the manual re-entry, or “swivel chair,” work that clinical trial sites previously had to perform between separate records systems. In October 2024, the company introduced Rave Lite, a version of Rave EDC built specifically for Phase I and Phase IV studies, extending access to smaller sponsors that had previously lacked resources for the full platform. Medidata reports more than 1 million registered platform users across roughly 2,300 customers, and has been recognized as a market leader by both Everest Group and IDC.

Medrio

Medrio operates an integrated CDMS/EDC, eCOA/ePRO, eConsent, and RTSM suite built to be configured without a programmer, backed by a services team the company describes as having 300 combined years of clinical trial industry experience. Founded in 2005 and headquartered in San Francisco, the company launched AI-enabled reporting within its CDMS/EDC platform in January 2025, using machine learning and natural language prompts to speed up data exploration and visualization for study teams. In March 2025, Medrio expanded its RTSM offering to integrate natively with its CDMS/EDC platform, eliminating data silos between randomization and data capture and enabling mid-study protocol adaptability without a separate reconciliation process. The company states its mission is to improve 100 million lives through faster, more efficient, and more secure clinical trials, and reports its recent innovations have reduced study build timelines by four to six weeks.

OpenClinica

OpenClinica was the world's first commercial open-source clinical trial software for electronic data capture, and its core EDC platform now has more than 1,200 installations worldwide supported by a community of over 18,000 members. Founded in 2004 and headquartered in Waltham, Massachusetts, the company's EDC and clinical data management system has been used across large pharmaceutical sponsor programs as well as resource-constrained research settings, including multi-site trials run by the KEMRI-Wellcome Trust Research Programme across East Africa. OpenClinica's platform includes extensive integration capabilities, including FHIR, SMART on FHIR, direct lab system connections, and Apple Health, letting sponsors adapt the system to a range of data sources beyond manual entry. CEO Cal Collins leads the company's continued development of the platform, which spans EDC, eCOA, eConsent, randomization, and reporting functions within a single system.

Q-Square Business Intelligence (Q2BI)

Q-Square Business Intelligence (Q2BI) is a biometrics-focused CRO offering electronic data capture, clinical data management, medical coding, statistical programming, and biostatistics services, founded in 2009 by CEO Gary Huang and headquartered in Boxborough, Massachusetts. The company reports supporting more than 1,000 clinical studies and 34 successful NDA/BLA regulatory submission approvals, and says it was among the first CROs to adopt CDISC data standards, supporting the FDA's Project Orbis international review program. In March 2026, Q2BI spun off Janus Data Intelligence (JDIX), a clinical AI technology company originally incubated inside Q2BI, which launched two data-quality and real-time monitoring platforms called JDIQ and JDIM. In August 2026, Q2BI opened new offices in Taipei, Kuala Lumpur, and Melbourne, expanding its footprint across the Asia-Pacific region alongside its existing operations in the greater New York, Boston, and San Francisco markets.

Explore the full Electronic Data Capture landscape

The companies above represent a portion of a much larger field.

Diligent's platform includes over 160 Electronic Data Capture Vendors, with Vendor qualification data available on demand. Book a demo to see the vendors and qualification reports available on the platform.

This article is intended as an informational overview of vendors operating in this space. Inclusion on this list does not constitute an endorsement, recommendation, or qualification by Diligent.